Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists
AUTOR(ES)
Olefsky, Jerrold M.
FONTE
American Society for Clinical Investigation
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=380259Documentos Relacionados
- Peroxisome proliferator‐activated receptor γ agonists inhibit the proliferation and invasion of human colon cancer cells
- A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation
- Nitrolinoleic acid: An endogenous peroxisome proliferator-activated receptor γ ligand
- Peroxisome proliferator–activated receptor γ ligands and atherosclerosis: ending the heartache
- Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis